Ares Life Sciences, a Switzerland-based healthcare-focused investment group, has signed a definitive agreement to acquire the complete share capital of Planet Biopharmaceuticals. The agreement also includes the acquisition of Planet ...
Tags: Ares Life Sciences, Medicine